Cortexyme Secures $7,918,642 New Funding

  • Feed Type
  • Date
    1/5/2016
  • Company Name
    Cortexyme
  • Mailing Address
    329 Oyster Point South San Francisco, CA 94080 USA
  • Company Description
    Cortexyme is developing novel treatments for altering the course of Alzheimer’s and other neurological diseases.
  • Website
    http://www.cortexyme.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,918,642
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 13 investors participated in the offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy